F-085RESECTABLE OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER: DOES SURGERY HAVE A REAL ADVANTAGE?
نویسندگان
چکیده
منابع مشابه
Perspectives in Surgery of Oligometastatic Non-small-cell Lung Cancer
20-50% of patients with newly diagnosed non-small-cell lung cancer (NSCLC) have synchronous metastases. This dramatically affects survival and traditionally excludes patients from the spectrum of curative therapies. Nonetheless, studies have been performed to assess the role of surgery in Stage 4 NSCLC with metastases circumscribed to a single or limited number of organs, proposing the definiti...
متن کاملOligometastatic non-small-cell lung cancer: current treatment strategies
The oligometastatic disease theory was initially described in 1995 by Heilman and Weichselbaum. Since then, much work has been performed to investigate its existence in many solid tumors. This has led to subclassifications of stage IV cancer, which could redefine our treatment approaches and the therapeutic outcomes for this historically "incurable" entity. With a high incidence of stage IV dis...
متن کاملSurgery for non-small cell lung cancer.
BACKGROUND As part of an evaluation of the lung cancer surgery at Akershus University hospital we wanted to describe the lung cancer surgery programme, assess 30-day mortality and review complications. MATERIAL AND METHOD We retrospectively examined medical records of all patients undergoing potentially curative surgery for non-small-cell lung cancer. RESULTS The 99 patients operated on wer...
متن کاملOligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
OBJECTIVE To report the incidence, patterns of care, and outcomes of oligometastatic non-small cell lung cancer (NSCLC) in a rural practice setting in Norway. MATERIALS AND METHODS A retrospective analysis was conducted of all patients with stage IV NSCLC at the initial diagnosis who received active treatment in the central part of Nordland, a rural county in northern Norway, during the perio...
متن کاملA Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location. In addition, following initial curative therapy, many patients present with limited metastatic disease, or oligo-recurrence. Metastasis-directed, anti-cancer therapies may benefit t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Interactive CardioVascular and Thoracic Surgery
سال: 2016
ISSN: 1569-9293,1569-9285
DOI: 10.1093/icvts/ivw260.84